While traditional biologics continue to see strong market demand, the need for emerging therapies, such as regenerative medicines, has also given rise to a burgeoning pipeline. The biopharmaceutical industry has seen significant levels of investment going into clinical-stage projects for cell therapies, gene therapies, and other regenerative medicines over the past year (1) as efforts […]

FDA Breakthrough Device Designation

X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation – announced today that The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has granted its proprietary organ preservation solution, XT-ViVo®, and TimeSeal® Organ Transport Device, Breakthrough Device status. This designation is granted to products […]

In the past two years, the cold chain turned into one of the most talked-about aspects of healthcare. Biotechnology company X-Therma in Richmond, CA, plans to improve the cold steps in the bioprocessing of cell and gene therapies with biomimetics. Find the whole article here:  Genetic Engineering & Biotechnlogy News This article is taken from Genetic […]

Every day it seems you can find a headline somewhere describing the extraordinary progress scientists have made in developing cell and gene therapies for rare genetic diseases, a variety of cancers, and common ailments that affect most of the industrialized world. Genetic material is now common in vaccines, too, as scientists discovered that mRNA is […]

Existing and emerging biotech advances are transforming the way we preserve and transport donated organs. While their methods may vary, all share a common end goal: saving more lives. Find the whole article here: 

Living cells, tissues, and organs are more critical to medicine than ever before, but current cryopreservation techniques are not enough to keep these materials viable during storage and transport. Peptoids may provide the solution. Find the whole article here:  European Biopharmaceutical Review | April 2022 This article is taken from European Biopharmaceutical Review April 2022, pages 48-51. © […]

 Funding will advance its breakthrough product platform rewriting biopreservation and cold chain   RICHMOND, Calif. — December 22, 2021 — 6:00 AM PT —  X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation – has closed an oversubscribed $13M Series A funding round. The financing is led by LOREA AG, […]

Join X-Therma Inc. on Nov 21st 11AM PST | 2PM EST at the International Conference of Nanotech Planet. From nanoscience to global organ sharing, our CEO, Dr. Xiaoxi (Sofie) Wei, will share how X-Therma leads Biomimetic Nanoscience innovations in biopreservation, transforming the field of regenerative medicine with the mission of saving millions of lives. For more info:  https://nanotechplanet.net

What a wonderful celebration of the 7th anniversary we had on Halloween weekend! We truly appreciate the commitment and contribution of our dedicated team and supportive members. We are a team with a bold dream, with incredible resilience and perseverance aiming for excellency while tirelessly pushing the boundaries of science. Thank you all, for your […]

Having second thoughts about your existing cryopreservation solution and process? Join our CEO Xiaoxi (Sofie) Wei at 12:00pm PDT on Oct 30th and learn how XT-Thrive can resolve the legacy challenges in cryopreservation, successfully replacing DMSO and Serum to improve efficiency of your large scale cell production! Annual BioPacific Conference – “Passion for Better Medicine” […]